Valuation : Telix Pharmaceuticals Limited

Market Cap 5.32B 3.82B 3.29B 3.08B 2.81B 5.3B 365B 36.57B 14.27B 184B 14.32B 14.01B 610B P/E 2026 *
239x
P/E 2027 * 162x
Enterprise Value 5.75B 4.12B 3.55B 3.33B 3.04B 5.73B 394B 39.52B 15.42B 199B 15.48B 15.14B 660B EV / Sales 2026 *
4.19x
EV / Sales 2027 * 3.69x
Free-Float
83.1%
Yield 2026 *
-
Yield 2027 * -
1 day-0.45%
1 week-3.59%
Current month+9.64%
1 month+9.64%
3 months+19.66%
6 months+57.85%
Current year+39.11%
1 week 15.17
Extreme 15.17
16.52
1 month 13.95
Extreme 13.95
18.13
Current year 8.26
Extreme 8.26
18.13
1 year 8.26
Extreme 8.26
18.32
3 years 8.2
Extreme 8.2
31.97
5 years 3.55
Extreme 3.55
31.97
10 years 0.46
Extreme 0.46
31.97
Manager TitleAgeSince
Chief Executive Officer 51 03/01/2017
Director of Finance/CFO 61 31/07/2022
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 51 03/01/2017
Chairman 66 03/02/2026
Director/Board Member 68 19/06/2018
Date Insider Type Main position Quantity % Market Cap.
26/05/26 Free

Director

21,597 0.0064%
26/05/26 Free

Founder

339,845 0.1001%
26/05/26 Free

Director

21,597 0.0064%
Change 5-day change 1-year change 3-year change Capi.($)
-1.02%-3.59%+4.56%+40.87% 3.82B
-0.78%-1.42%+2.96%+20.82% 50.47B
-6.00%-0.75%+447.48%+524.26% 44.56B
-0.24%+0.74%+37.18%+16.57% 43.08B
-1.55%-2.07%+19.83%+73.63% 41.7B
-0.31%-0.83%+19.47%+48.24% 33.21B
-1.79%-3.24%+26.32%+121.63% 16.77B
-0.58%-2.12% - - 16.28B
-0.88%-0.66%+11.63%+28.71% 14.58B
-1.66%-1.25%+78.49%+39.02% 13.92B
Average -1.42%-0.93%+71.99%+101.53% 27.84B
Weighted average by Cap. -1.69%-1.04%+94.94%+125.73%

Financials

2026 *2027 *
Net sales 1.37B 983M 847M 794M 725M 1.37B 93.98B 9.43B 3.68B 47.44B 3.69B 3.61B 157B 1.58B 1.13B 975M 914M 834M 1.57B 108B 10.84B 4.23B 54.57B 4.25B 4.15B 181B
Net income 25.05M 17.97M 15.49M 14.52M 13.26M 24.97M 1.72B 172M 67.22M 867M 67.48M 66.01M 2.88B 19.91M 14.29M 12.31M 11.54M 10.54M 19.85M 1.37B 137M 53.43M 689M 53.64M 52.47M 2.29B
Net Debt 429M 308M 265M 249M 227M 428M 29.42B 2.95B 1.15B 14.85B 1.16B 1.13B 49.25B 498M 357M 308M 288M 263M 496M 34.12B 3.42B 1.34B 17.23B 1.34B 1.31B 57.12B
Logo Telix Pharmaceuticals Limited
Telix Pharmaceuticals Limited is an Australia-based biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. It is developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases. Its segments include Therapeutics, Precision Medicine and Telix Manufacturing Solutions. Therapeutics segment develops targeted radionuclide therapies for urologic, neurologic, musculoskeletal and hematological cancers. Precision Medicine segment focuses on bringing diagnostic imaging solutions to market. Precision Medicine segment also includes MedTech and International businesses. Telix Manufacturing Solutions segment is its global network of facilities designed to deliver patient doses worldwide. Its pipeline products include TLX591, TLX250, TLX101, TLX66, TLX592, TLX252, TLX400, Illuccix (68Ga-PSMA-11) and TLX007-CDx.
Employees
1,152
Date Price Change Volume
31/08/26 A$15.49 -1.02% 83,497
28/08/26 A$15.65 +0.45% 985,671
27/08/26 A$15.58 +0.58% 1,273,984
26/08/26 A$15.49 -4.15% 1,504,493
25/08/26 A$16.16 0.00% 995,818
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
15.65AUD
Average target price
23.44AUD
Spread / Average Target
+49.75%

Quarterly revenue - Rate of surprise